All Industries

NobleMarriage Launches Advanced Matrimonial App for Muslims Seeking Life Partners

Rev Up Marketers

NobleMarriage, an online matrimonial platform dedicated to helping practicing Muslims find life partners globally, has launched its new Android app. The app features a user-friendly interface while strictly adhering to halal and Shariah values, bolstering a dignified and respectful matchmaking service. With the newly launched app, users can benefit from advanced and personalized search options, robust anti-scam protection, and verified member profiles. Key functionalities include live chat, photo requests, and user shortlisting, catering to a diverse user base and allowing for anonymous connections and controlled profile preferences. NobleMarriage's rigorous review process during registration ensures that only real and verified members can join. This thorough verification includes phone number, email address, and profile picture verification, guaranteeing genuine profiles. The app's advanced algorithms consider preferences such as education level, career choice, location, and social background, enabling instant matches between individuals with similar interests. Female users can keep their photos blurred until they respond to a photo request. Male users also have the option to keep their photos blurred or visible, according to their preferences. Some of the key features of the NobleMarriage App are as follows: Data Protection System: The app employs advanced anti-fraud and data protection systems to create a secure environment, giving users confidence in their search for a life partner. Verification of Every Profile: A dedicated moderation team meticulously verifies every profile on the app, ensuring that only genuine marriage seekers are present. Halal Features: Noble Marriage offers features aligned with Islamic values, including personalized inboxes, blurred images, photo requests, and search filters, preserving privacy and faith adherence. Global User Base: NobleMarriage caters to an international Muslim community and facilitates global connections. Focus on Marriage: The app is dedicated solely to helping Muslims find life partners, discouraging dating-type behavior, and upholding the values of marriage. Getting Started with Noble Marriage is easy. Users must create an account, verify their profile, select and connect with suitable matches, and start the conversation to find their soulmate. For more information and to download the app, visit their website. About NobleMarriage: NobleMarriage is a professional Muslim matchmaker platform designed to help practicing Muslims find life partners in a manner that adheres to Islamic values. The newly launched app makes Noble Marriage's services more accessible and efficient for users. With a focus on safety, authenticity, and halal features, NobleMarriage serves a global community, providing a respectful environment for finding a soulmate. Contact Details NobleMarriage Shaher Al Rahman +44 7501 247364 info@noblemarriage.com Company Website https://noblemarriage.com/

June 03, 2024 07:37 AM Eastern Daylight Time

BestGrowthStocks.com Issues Comprehensive Evaluation of GameStop Corporation

Game Stop Corp

Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive evaluation of GameStop Corp. a Fortune 500 and S&P 500 company that operates as a global, multichannel video game, consumer electronics, and collectibles retailer. GameStop Corp. (NYSE: GME) has recently caught the attention of many investors following the meme-stock rally revitalization and other subsequent events covered in this report. Best Growth Stock's full report breaks through the noise and offers a comprehensive analysis of GameStop’s operations, financials, up to date outstanding shares, recent capital raise, chart setup, possible catalysts, management and much more. Access this full analysis free: https://bestgrowthstocks.com/access-gme-analysis/ (If you cannot click the link above, copy and paste to your browser may be required) Access this full analysis free: https://bestgrowthstocks.com/access-gme-analysis/ (If you cannot click the link above, copy and paste to your browser may be required) About GameStop GameStop Corporation (NYSE: GME) is a Fortune 500 and S&P 500 company that operates as a global, multichannel video game, consumer electronics, and collectibles retailer. The company was founded in 1996 and is headquartered in Grapevine, Texas. About Best Growth Stocks Best Growth Stocks is a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing our exclusive ai-assisted research. BGS is also a financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts. Our CEO interviews aim to answer the questions that rest on the minds of current and future shareholders. This is not to be construed as financial advice. Please consult with a licensed financial advisor before making any investment decisions. Media Contact Best Growth Stocks Senior Editor: Steve Macalbry Editor@BestGrowthStocks.com SOURCE: BestGrowthStocks.Com Contact Details Best Growth Stocks Steve Macalbry Editor@bestgrowthstocks.com

June 03, 2024 07:30 AM Eastern Daylight Time

Image

News Release

Sector Spotlight: Orphan Drug Developers With Significant Upside

RazorPitch CRDL, KNSA

The biotech sector is finally beginning to recover following a two year stretch of underperformance that was largely driven by rising interest rates and other macro factors. Biotech has a track record of strong recoveries, with the sector typically seeing double-digit gains after a downturn. This is something investors shouldn’t ignore. This recent turnaround can be credited to a robust increase in fundraising efforts and an uptick in IPOs, reaching levels not seen since the peak of the mid-pandemic market boom. According to the Financial Times, drug developers raised $6 billion in equity capital markets in January, the largest total since February 2021 – a period when biotech stocks hit their all-time high. Moreover, the SPDR S&P Biotech ETF (XBI) returned 28.7% over the past six months alone, clearly illustrating investors' rising confidence in the biotech rebound. Identifying biotech stocks with the potential to deliver superior returns is no easy feat. There are specific milestones that companies can achieve to signal positive momentum to investors. For example, smaller biotech companies may have received the nod from regulatory authorities such as the FDA, or new breakthroughs from clinical trials, to offer a compelling investment opportunity. With that in mind, two stocks that investors should consider looking at are Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL) and Kiniksa Pharmaceuticals (NASDAQ:KNSA). Cardiol Therapeutics lead product is CardiolRx™, a small molecule therapy that appears on track to bring major disruption to the pericarditis market. CardiolRx™ received a vote of confidence as it was granted Orphan Drug Designation (ODD) by the FDA for the treatment of pericarditis back in February, illustrating the potential of the drug. Apart from providing a seven-year term of market exclusivity upon final FDA approval, the ODD also positions Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL) to be able to leverage a wide range of financial and regulatory benefits, including government grants for conducting clinical trials, waiver of expensive FDA user fees, and certain tax credits. The U.S. Orphan Drug Act is intended to assist and encourage companies to develop safe and effective therapies for the treatment of rare diseases and disorders, defined as one that affects fewer than 200,000 people in the U.S. There are approximately 160,000 cases of recurrent pericarditis in the U.S. annually, which includes 38,000 cases with a recurrence. Having secured FDA approval, Cardiol Therapeutics is an exemplary company likely to attract biotech investors seeking assurance in smaller firms. While the stock had a significant rally on the backdrop of this news and continues to show strength, we believe that there is still potential for further upside. Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL) is expected to release topline data in June for its Phase 2 MAvERIC-Pilot clinical trial, which if positive, could unlock significant shareholder value. Several analysts have already indicated that they are highly optimistic that the data could be a catalyst, with one analyst noting that “CardiolRx’s potential to be a safe, new approach to RP (recurrent pericarditis) treatment is underappreciated.” CardiolRx™ stands out when compared to the only FDA-approved therapy because it is administered orally and expected to be offered as a first-line therapy for pericarditis, opening it up to an even bigger opportunity as it could be prescribed at the first occurrence. Orphan drugs have become lucrative business opportunities because these drugs command premium drug pricing, with the average price for an orphan drug at $32,000 per year per patient according to a 2021 study published in the journal Rare Diseases & Journal of Orphan Drugs. That could explain why analysts who have been tracking CRDL are so bullish on the stock. For instance, Joe Gantoss of Chimera Research Group says he won’t be surprised to see Cardiol’s price break past the 3-year high at $4.96, while analyst Vernon Bernardino of H.C. Wainwright & Co. reiterated their Buy rating and issued a $9.00 price target. That would imply that Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL) has a potential upside of about 300% from its current share price. Kiniksa Pharmaceuticals (NASDAQ:KNSA) offers some insight into the revenue potential of an orphan drug that treats recurrent pericarditis. So far, KNSA has had a great run, gaining about 36% over the past year and trading at about $18.00 per share despite challenges in the sector. It is currently valued at $1.3 billion. Kiniksa’s portfolio of assets includes ARCALYST®, the first and only FDA-approved therapy for recurrent pericarditis. For some context, the FDA granted Breakthrough Therapy designation to ARCALYST® for recurrent pericarditis in 2019; the FDA granted Orphan Drug exclusivity to ARCALYST® in March 2021 for the treatment of recurrent pericarditis and a reduction in the risk of recurrence in adults and pediatric patients 12 years of age and older. The European Commission granted Orphan Drug Designation to ARCALYST for the treatment of idiopathic pericarditis in 2021. Sales of ARCALYST® were $38.5 million in 2021; $122.5 million in 2022; $233.2 million in 2023 further reaffirming the massive revenue potential for treating recurrent pericarditis. For the first quarter of 2024, ARCALYST® sales were $78.9 million representing 85% year-over-year growth. Furthermore, since its launch in April 2021, approximately 2,000 prescribers have written ARCALYST® prescriptions for recurrent pericarditis, illustrating the massive demand for effective recurrent pericarditis therapies. Going forward, Kiniksa anticipates that it will bring in between $370 million and $390 million in 2024, up from the earlier guidance of $360 million to $380 million. The revised outlook represents roughly 63% year-over-year growth at the midpoint. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Cardiol Therapeutics to assist in the production and distribution of content related to CRDL. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Inc Mark McKelvie +1 585-301-7700 Mark@razorpitch.com Company Website http://razorpitch.com

June 03, 2024 07:00 AM Eastern Daylight Time

UFC and Aires Tech Inc. Join Forces to Reach a Global Audience of 700 Million Fans

AAIRF, EDR, TKO

In a world increasingly reliant on technology, concerns about electromagnetic radiation (EMR) have led to a surge in demand for innovative solutions. American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) has been making significant strides in the tech industry with its cutting-edge approach to electromagnetic radiation (EMF) protection. The US market for EMF protection is estimated to be worth $5 billion, representing only a small portion of the even larger global opportunity. With the announcement of a multi-year global marketing partnership with UFC last week, now could be the time to take a look at AAIRF. The UFC Collaboration: AAIRF's visibility will increase significantly as a result of the partnership with UFC, the top mixed martial arts organization and a division of TKO Group Holdings (NYSE:TKO), which Endeavor Group Holdings, Inc. (NYSE: EDR) owns a majority stake in. With UFC’s reach extending to over 700 million fans in 170 countries and approximately 975 million households, this collaboration is poised to place Aires Tech in front of a massive global audience. The integration of Aires branding within UFC’s major events, including pay-per-view broadcasts and other media, will provide unparalleled reach. Grant Norris-Jones, Head of Global Partnerships at TKO, highlighted the synergy between the two brands: “Aires aligns well with our brand in several respects, including their focus on innovation and being a first mover in their industry.” Josh Bruni, CEO of Aires, emphasized the benefits of the partnership: “This collaboration not only amplifies our global reach but also connects us with UFC's dedicated audience, who value peak performance and personal well-being.” The partnership was activated at UFC 302: Makhachev vs. Poirier on June 1, 2024, marking a significant milestone in Aires' journey to become a global leader in EMF protection technology. The company hopes that this collaboration is expected to drive brand awareness and sales growth, solidifying Aires’ position as a leader in the market. Innovative Technology: The exclusive silicon-based resonator technology from Aires is intended to block dangerous electromagnetic radiation (EMR) released by consumer electronics. This innovation is embodied in their Lifetune products, which target EMR from cellphones, computers, baby monitors, Wi-Fi, and high-speed 5G networks. With over 20 years and $20 million invested in research and development, Aires has positioned itself as a pioneer in the field of EMR protection. The company's products appeal to a wide range of customers, including biohackers, athletes, individuals concerned with fertility, and those seeking better sleep. Aires operates a direct-to-consumer sales model with fulfillment centers in the USA, Canada, Australia, and the EU, and has recently established a new center in the UK to support its global expansion efforts. Financial Strength and Growth Trajectory: American Aires Inc. has demonstrated robust financial performance, with gross margins averaging around 60%. This is comparable to top technology companies like Nvidia and Apple, which boast gross margins of 75% and 45%, respectively. The company achieved positive EBITDA (adjusted) in its most recent quarter, underscoring its strong financial health. In fiscal year 2023, Aires reported a record annual order volume of $10.4 million, a 79% increase year-over-year. The company's direct-to-consumer business now ships products to over 60 countries, with significant growth observed in Australia and the EU. In Q1 2024, Aires reported a 37% year-over-year increase in sales, despite typical Q1 consumer spending weaknesses. The company's cash balance also saw a substantial improvement, increasing from $0.03 million in Q4 2023 to $2.3 million in Q1 2024, bolstered by successful financings in February and May 2024. CEO Josh Bruni stated, “Now that Q1 and our heavy lifting on the IR front are behind us, we're refocusing our efforts on deploying the capital we raised across three major fronts: forging prominent new marketing partnerships, building universal brand awareness, and expanding internationally. In other words, continuing to do what's enabled our multi-year trajectory of significant revenue growth so we can make 2024 our best year ever.” Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Clarkham Capital to assist in the production and distribution of content related to AAIRF/WIFI. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Inc. Mark McKelvie +1 585-301-7700 Mark@razorPitch.com Company Website http://razorpitch.com

June 03, 2024 06:00 AM Eastern Daylight Time

Tron and Ethereum Lose Momentum, Raboo Set To Surge 10x in June

Total Media

Although the crypto market is generally bullish, popular tokens like Tron and Ethereum are not performing as expected. Tron's protracted legal battles with the SEC and the delay in the official trading of the Ethereum ETF have been identified as probable causes. Meanwhile, investors remain confident in the revolutionary memetoken Raboo (RABT), which is currently gaining momentum in its presale, with over $1.5 million worth of the token sold already. Also, with a potential to surge by 10x in June, Raboo is rapidly becoming one of the best cryptos to invest in this year. Tron’s legal battles slow down momentum after price slump Tron continues to face significant legal challenges from the United States Securities and Exchange Commission (SEC). The SEC lawsuit against Tron, which has slowed down its market activity, alleges that Tron's TRX token is a security. The SEC further claimed that the sales of these tokens were not legal since they are unregistered securities offerings. Tron has firmly disputed these claims, stating that the SEC's allegations are "tenuous at best." Furthermore, Tron claims that the SEC is not a "worldwide regulator" and that its attempt to apply U.S. securities laws to "predominantly foreign conduct" goes "too far." This stance is consistent with the firm's headquarters being in Singapore. The ongoing legal challenges have impacted Tron's momentum given that Tron has been down by more than 6% for a month. Crypto analysts have identified its ongoing legal battles as the root of this decline, given that investors have become increasingly cautious about investing in Tron’s platform with the ongoing regulatory issues. Ethereum’s ETF trading delay slows price growth Ethereum's recent rally has fizzled out, indicating a loss of momentum even though backers of the project continue to affirm that it is still one of the best crypto to invest in this year. The token is expected to witness increased trading activity due to the approval of spot Ethereum exchange-traded funds (ETFs) by the United States Securities and Exchange Commission (SEC), however, the ETFs are yet to commence trading officially as investors await the respective Form S-1 approval for each fund. This development has led crypto analysts to speculate that the uncertainty that accompanies such inactive moments could spell trouble for Ethereum's price, particularly given the high futures open interest that rose to its highest level ever on May 28. The recent approval of 19b-4s forms issued by the Ethereum ETF issuers does not mean that trading in Ethereum ETFs has begun. The S-1 forms, which include detailed financial and risk information, are yet to be approved by the SEC and could take weeks. This delay in trading has contributed to the lack of market activity which has slowed down growth and has led crypto analysts to believe that Ethereum would continue to lose momentum in the meantime. Raboo tipped to 10X in June as AI meme coin surges on massive adoption Raboo, the new AI meme coin, is expected to surge 10x in June, according to analysts. This prediction is based on the token's unique social-fi model, which allows holders to earn extra tokens by competing in challenges and giveaways. Crypto enthusiasts also stand the chance to earn returns by engaging the platform. Raboo's integration of AI technology continues to drive its growth, positioning it as one of the best altcoins to buy in 2024. While massive purchase of its presale token that has now exceeded the $1.5 million mark is projected to inspire a 10x surge in June, crypto analysts have also predicted that Raboo's price will grow 233% during the presale and 100x on launch day. This rapid growth is attributed to the token's innovative features that are designed to attract memecoin enthusiasts. Raboo's surge in June is expected to be 10x after being tipped as the best altcoin to buy in 2024. Raboo is well-positioned to become one of the best altcoins in the industry as more crypto enthusiasts join the platform, increasing its strong community while its innovative features continue to captivate investors. Investors looking for a high-growth opportunity should consider Raboo, which is expected to 100x this year. Conclusion Tron and Ethereum continue to face challenges amidst ongoing lawsuits and reduced trading activity that has inspired a loss of momentum for both tokens. Meanwhile, Raboo, an innovative memecoin that has been tipped as the best crypto to buy in 2024, continues to attract more investors after record surge positioning it for massive returns in June and lucrative returns for investors upon launch. You can participate in the Raboo presale here Telegram: https://t.me/RabootokenPortal Twitter: https://twitter.com/Raboo_Official Contact Details Total Media Solutions media@Totalsolutionspr.io

June 02, 2024 02:13 PM Eastern Daylight Time

Image

Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold

AffiliateAvenue

Affiliate Avenue, the newsdirect.com channel for compelling affiliate marketing content, has recently posted an article by Jeannine Mancini of Benzinga Money entitled: Can You Guess How Many Americans Successfully Retire With $1 Million Saved? The Percentage May Shock You Mancini reviews the shockingly low percentage of Americans who have amassed the recommended minimum retirement nest egg to live a comfortable post-employment lifestyle. The article provides a free retirement quiz and offers to connect readers with vetted fiduciary financial advisors via a free tool from SmartAsset. Contact Details News Direct Media at News Direct success@newsdirect.com Company Website https://newsdirect.com/affiliate-avenue

June 01, 2024 02:25 PM Eastern Daylight Time

HTX Ventures Invests in Babylon to Advance Trustless Bitcoin Staking

HTX Ventures

Singapore / May 31, 2024 – HTX Ventures, the global investment arm of the cryptocurrency exchange HTX, has announced a strategic investment in Babylon, a Bitcoin staking protocol. This investment underlines HTX Ventures’ commitment to fostering innovation and supporting groundbreaking technologies in the blockchain and cryptocurrency sectors. Babylon builds infrastructure that allows proof-of-stake systems to obtain staking capital from Bitcoin. The platform uses modular design and slashing functionality to let stake-base systems, such as blockchains, Layer 2s, DA layers and oracles, and incorporates Bitcoin as a staking and restaking asset. "HTX Ventures is excited to support Babylon's pioneering efforts in harnessing Bitcoin for decentralized security," said Edward, Managing Partner of HTX Ventures. "Babylon’s trustless design unlocks new possibilities for Bitcoin, transforming its utility and paving the way for innovative Bitcoin-native applications. We believe Babylon will play a crucial role in advancing the blockchain ecosystem, and are proud to be a part of this transformative journey." "This funding will accelerate our mission to make Bitcoin the security backbone of PoS systems," Babylon co-founder David Tse said in a statement. "Our team is dedicated to advancing the utility of Bitcoin beyond its traditional roles and enhancing the security of the entire blockchain ecosystem." Babylon recently raised $70 million in a funding round led by the venture firm Paradigm. In February 2024, Babylon launched the world’s first trustless Bitcoin staking testnet, attracting over 100,000 stakers within 48 hours. This remarkable response highlights the platform’s potential to transform Bitcoin into the security backbone of PoS systems. This achievement underscores Babylon’s technical expertise and commitment to fostering a secure, decentralized economy. About HTX Ventures HTX Ventures, the global investment division of HTX, integrates investment, incubation, and research to identify the best and brightest teams worldwide. With a decade-long history as an industry pioneer, HTX Ventures excels at identifying cutting-edge technologies and emerging business models within the sector. To foster growth within the blockchain ecosystem, we provide comprehensive support to projects, including financing, resources, and strategic advice. HTX Ventures currently backs over 200 projects spanning multiple blockchain sectors, with select high-quality initiatives already trading on the HTX exchange. Furthermore, as one of the most active Fund of Funds (FOF) investors, HTX Ventures collaboratively forges the blockchain ecosystem alongside premier global blockchain funds, including IVC, Shima, and Animoca. Contact Details Michael Wang glo-media@htx-inc.com Company Website https://www.htx.com/en-us/ventures About HTX Ventures HTX Ventures, the global investment division of HTX, integrates investment, incubation, and research to identify the best and brightest teams worldwide. With a decade-long history as an industry pioneer, HTX Ventures excels at identifying cutting-edge technologies and emerging business models within the sector. To foster growth within the blockchain ecosystem, we provide comprehensive support to projects, including financing, resources, and strategic advice. HTX Ventures presently backs over 200 projects spanning multiple blockchain sectors, with select high-quality initiatives already trading on the HTX exchange. Furthermore, as one of the most vigorous Fund of Funds (FOF) investors, HTX Ventures collaboratively forges the blockchain ecosystem alongside premier global blockchain funds, including IVC, Shima, and Animoca. Contact Details Michael Wang glo-media@htx-inc.com Company Website https://www.htx.com/en-us/ventures

May 31, 2024 10:58 PM Eastern Daylight Time

Direxion Announces Reverse Split of JDST

Direxion

CONTACT: Danielle Black, SAE Ditto Public Relations direxion@dittopr.co NEW YORK —May 31, 2024— Direxion, a leading provider of tradeable and thematic ETFs, has announced it will execute a reverse split of the issued and outstanding shares of the Direxion Daily Junior Gold Miners Index Bear 2X Shares (Ticker: JDST ) (the “Fund”). The total market value of the shares outstanding will not be affected as a result of this split, except with respect to the redemption of fractional shares, as outlined below. After the close of the markets on June 28, 2024 (the “Effective Date”), the Fund will effect a reverse split of its issued and outstanding shares as follows: Please note the CUSIP change, effective July 1, 2024: As a result of this reverse split, every ten shares of the Fund will be exchanged for one share as indicated in the table above. Accordingly, the total number of the issued and outstanding shares for the Fund will decrease by the approximate percentage indicated above. In addition, the per share net asset value (“NAV”) and next day’s opening market price will be approximately ten-times higher for the Fund. Shares of the Fund will begin trading on the NYSE Arca, Inc. (the “NYSE Arca”) on a split-adjusted basis on July 1, 2024. The next day’s opening market value of the Fund’s issued and outstanding shares, and thus a shareholder’s investment value, will not be affected by the reverse split. The table below illustrates the effect of a hypothetical one-for-ten reverse split anticipated for the Fund: 1-for-10 Reverse Split Redemption of Fractional Shares and Tax Consequences of the Reverse Split As a result of the reverse split, a shareholder of the Fund’s shares potentially could hold a fractional share. However, fractional shares cannot trade on the NYSE Arca. Thus, the Fund will redeem for cash a shareholder’s fractional shares at the Fund’s split-adjusted NAV as of the Effective Date. Such redemption may have tax implications for those shareholders and a shareholder could recognize a gain or loss in connection with the redemption of the shareholder’s fractional shares. Otherwise, the reverse split will not result in a taxable transaction for holders of Fund shares. No transaction fee will be imposed on shareholders for such redemption. “Odd Lot” Unit Also, as a result of the reverse split, the Fund may have outstanding one aggregation of less than 50,000 shares to make a creation unit, or an “odd lot unit.” Thus, the Fund will provide one authorized participant with a one-time opportunity to redeem the odd lot unit at the split-adjusted NAV or the NAV on such date the authorized participant seeks to redeem the odd lot unit. The Direxion Shares ETF Trust’s transfer agent will notify the Depository Trust Company (“DTC”) of the reverse split and instruct DTC to adjust each shareholder’s investment(s) accordingly. DTC is the registered owner of the Fund’s shares and maintains a record of the Fund’s record owners. All Direxion leveraged and inverse ETFs are intended only for investors with an in-depth understanding of the risks associated with seeking leveraged investment results, and who plan to actively monitor and manage their positions. There is no guarantee these ETFs will meet their objective. Please visit the Direxion Leveraged and Inverse ETF Education Center, where you will find educational brochures, videos, and a self-paced online course to help you understand if leveraged ETFs are right for you. About Direxion: Direxion equips investors who are driven by conviction with ETF solutions built for purpose and fine-tuned for precision. These solutions are available for a broad spectrum of investors, whether executing short-term tactical trades, or investing in thematic strategies. Direxion’s reputation is founded on developing products that precisely express market perspectives and allow investors to manage their risk exposure. Founded in 1997, the company has approximately $42.3 billion in assets under management as of March 31, 2024. For more information, please visit www.direxion.com. There is no guarantee that the Fund will achieve its investment objective. For more information on all Direxion Shares ETFs, go to www.direxion.com, or call us at 866.301.9214. An investor should carefully consider the Fund’s investment objective, risks, charges, and expenses before investing. The Fund’s prospectus and summary prospectus contain this and other information about the Direxion Shares. To obtain a prospectus and summary prospectus call 866-476-7523 or visit our website at direxion.com. The Fund’s prospectus and summary prospectus should be read carefully before investing. Leveraged and Inverse ETFs pursue daily leveraged investment objectives which means they are riskier than alternatives which do not use leverage. They seek daily goals and should not be expected to track the underlying index over periods longer than one day. They are not suitable for all investors and should be utilized only by sophisticated investors who understand leverage risk and who actively manage their investments. Direxion Shares Risks – An investment in the Fund involves risk, including the possible loss of principal. The Fund is non-diversified and includes risks associated with the Fund concentrating its investments in a particular industry, sector, or geographic region, which can result in increased volatility. The use of derivatives, such as futures contracts and swaps, are subject to market risks that may cause their price to fluctuate over time. Risks of the Fund include Effects of Compounding and Market Volatility Risk, Leverage Risk, Market Risk, Counterparty Risk, Rebalancing Risk, Intra-Day Investment Risk, Other Investment Companies (including ETFs) Risk, Cash Transaction Risk, Passive Investment and Index Performance Risk, and risks specific to investment in the securities of gold and silver mining companies and the mining and metal industry, which are included in the materials sector. Because the Index is concentrated in the gold mining industry, and may have significant exposure to assets in the silver mining industry, the Fund will be sensitive to changes in the overall condition of gold- and silver-related companies. Competitive pressures may have a significant effect on the financial condition of gold- and silver-related companies. Additional risks for the Fund include Shorting or Inverse Risk and Daily Inverse Index Correlation Risk. Please see the summary and full prospectus for a more complete description of these and other risks of the Fund. Non-Physical Commodities Disclosure – This fund tracks a commodity related equity index, consisting of a basket of oil and gas related stocks. It does not invest in physical commodities and should not be expected to directly track the price performance of oil and gas commodities. Distributor: Foreside Fund Services, LLC. Contact Details Ditto PR Danielle Black direxion@dittopr.co Company Website https://www.direxion.com/

May 31, 2024 05:32 PM Eastern Daylight Time

Youri Unveils New Range of Premium Phone Cases for iPhone and Samsung Galaxy Devices

Rev Up Marketers

Youri, a leader in mobile accessories, proudly announces the launch of its latest line of phone cases designed for iPhone and Samsung Galaxy devices. Now available, these cases merge high-level protection with elegant styling, ensuring smartphones are both secure and stylish. Discover the full range of products at www.youri.com. Made from top-quality materials, Youri's new phone cases deliver outstanding protection against drops, bumps, and scratches. Each design is precision-engineered to fit perfectly with the device, providing hassle-free access to all buttons, cameras, and ports. The collection includes a range of styles, from minimalist clear cases that highlight the phone's design to boldly textured cases that stand out. "Our new collection of phone cases represents a perfect synergy of protective technology and aesthetic design," said the Youri Marketing Team. "We recognize that our customers want accessories that are both functional and fashionable, and we've responded with a line of cases that meet these needs while also offering superior protection." Highlights of the Youri phone cases include shock-absorbent corners, anti-scratch coatings, and raised bezels to protect screens from direct contact with surfaces. Emphasizing environmental responsibility, Youri has integrated eco-friendly materials into several new case designs. Youri phone cases are now available for purchase on the company’s website. Customers can take advantage of an exclusive introductory discount on all orders for a limited time. Explore the collection and select the perfect case for your iPhone or Samsung Galaxy at www.youri.com. About Youri In April 2020, Youri launched SendUsMasks to provide affordable, high-quality reusable cloth masks, combating price gouging during uncertain times. Their dedication to people in need earned them over 1,700 five-star reviews and saved thousands of lives. Rebranded as Youri, they now focus on offering top-quality phone cases for iPhone and Samsung Galaxy devices, maintaining their commitment to customer trust and satisfaction. Contact Details Youri Stevan Shlemoon +1 844-958-2919 hello@youri.com Company Website https://youri.com/

May 31, 2024 04:53 PM Eastern Daylight Time

Image

1 2 3 4 5 ... 3593